Kie Abe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kie Abe has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Yuhei Chiba
Yokohama City University Graduate shool of medicine, Department of Psychiatry, Yokohama, Kanagawa, Japan; Sekiaikai Yokohama Maioka Hospital, Yokohama, Kanagawa, Japan; YUAD, Yokohama, Kanagawa, Japan
5 shared publications - Hiroko Suzuki
SOMPO Care Inc. Shinagawa-ku, Tokyo, Japan
3 shared publications - Keiko Ide
Yokohama City University Graduate shool of medicine, Department of Psychiatry, Yokohama, Kanagawa, Japan
3 shared publications - Kyoko Saito
Shukutoku University, Saitama-shi, Saitama, Japan
3 shared publications - Masataka Taguri
Department of Health Data Science Tokyo Medical University Tokyo Japan
3 shared publications - Shoko Suzuki
Graduate School of Data Science, Yokohama City University, 22 Seto, Kanazawa-ku, Yokohama, Kanagawa 236-0027, Japan; Daiichi Sankyo, Co., Ltd., Tokyo, Japan
3 shared publications
Latest Publications
- Open Access
- 22 May 2026
- Published by Elsevier in Archives of Gerontology and Geriatrics Plus
- Vol. 3 (3)
Association between activity levels and sleep in Community-Dwelling older adults: Insights from a dementia prevention trial using wearable devices
- 22 May 2026
- Published by Elsevier in Archives of Gerontology and Geriatrics Plus
- Vol. 3 (3)
Open AccessAssociation between activity levels and sleep in Community-Dwelling older adults: Insights from a dementia prevention trial using wearable devices
- 5 May 2026
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 149, 106289
Multimodal intervention benefits: Responder analysis of J-MINT PRIME Kanagawa trial
- 5 May 2026
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 149, 106289
Multimodal intervention benefits: Responder analysis of J-MINT PRIME Kanagawa trial
- 1 July 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 106 (2) , 574-588
Japan-multimodal intervention trial for the prevention of dementia in older people with lifestyle-related diseases: A community-based, 18-month, randomized controlled trial
Background: The prevalence of Alzheimer's disease is increasing in Japan, highlighting the need to establish evidence-based strategies for its prevention. Objective: We aimed to evaluate the effectiveness of a multimodal community-based intervention for Japanese older people with lifestyle-related diseases and to identify challenges in implementing such interventions to prevent dementia in local communities. Methods: An 18-month randomized controlled trial was conducted among individuals aged 65–85 years with lifestyle-related diseases (hypertension, hyperlipidemia, diabetes, overweight/underweight, smoking), residing in a single apartment complex. Participants were randomly assigned to a multimodal intervention group (group-based physical exercise, nutritional guidance, management of lifestyle-related diseases, and cognitive training) or a control group. The primary outcome was the change in the composite score derived from seven neuropsychological tests. The trial was registered (UMIN000041887: September 24, 2020). Results: Of 224 screened individuals, 198 were randomized (99 in each group), and 175 (88.4%) completed the 18-month assessment. There was no significant difference between the intervention and control groups in the primary outcome (change in composite test score: 0.25; 95% confidence interval 0.16 to 0.33 versus 0.29; 95% confidence interval 0.20 to 0.38, respectively; p = 0.463). However, a subgroup analysis of participants with mild cognitive impairment showed a significant intervention effect on changes in logical memory, for both immediate ( p = 0.041) and delayed recall tasks ( p = 0.043). Conclusions: This multimodal intervention program demonstrated no effectiveness in mitigating cognitive decline. Further research is needed to develop more effective strategies and to better define target populations.
- 1 July 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 106 (2) , 574-588
Japan-multimodal intervention trial for the prevention of dementia in older people with lifestyle-related diseases: A community-based, 18-month, randomized controlled trial
Background: The prevalence of Alzheimer's disease is increasing in Japan, highlighting the need to establish evidence-based strategies for its prevention. Objective: We aimed to evaluate the effectiveness of a multimodal community-based intervention for Japanese older people with lifestyle-related diseases and to identify challenges in implementing such interventions to prevent dementia in local communities. Methods: An 18-month randomized controlled trial was conducted among individuals aged 65–85 years with lifestyle-related diseases (hypertension, hyperlipidemia, diabetes, overweight/underweight, smoking), residing in a single apartment complex. Participants were randomly assigned to a multimodal intervention group (group-based physical exercise, nutritional guidance, management of lifestyle-related diseases, and cognitive training) or a control group. The primary outcome was the change in the composite score derived from seven neuropsychological tests. The trial was registered (UMIN000041887: September 24, 2020). Results: Of 224 screened individuals, 198 were randomized (99 in each group), and 175 (88.4%) completed the 18-month assessment. There was no significant difference between the intervention and control groups in the primary outcome (change in composite test score: 0.25; 95% confidence interval 0.16 to 0.33 versus 0.29; 95% confidence interval 0.20 to 0.38, respectively; p = 0.463). However, a subgroup analysis of participants with mild cognitive impairment showed a significant intervention effect on changes in logical memory, for both immediate ( p = 0.041) and delayed recall tasks ( p = 0.043). Conclusions: This multimodal intervention program demonstrated no effectiveness in mitigating cognitive decline. Further research is needed to develop more effective strategies and to better define target populations.
- 1 January 2021
- Published by Elsevier in Neuroscience Letters
- Vol. 743, 135588
Exploratory investigation on antibodies to GluN1 and cognitive dysfunction in patients with chronic autoimmune psychosis
- 1 January 2021
- Published by Elsevier in Neuroscience Letters
- Vol. 743, 135588
Exploratory investigation on antibodies to GluN1 and cognitive dysfunction in patients with chronic autoimmune psychosis